Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ono

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ono's Japan sales performance.

Immuno-oncology in 2019: the rapid evolution continues

Immuno-oncology in 2019: the rapid evolution continues BMS led the charge when Opdivo became the first in its class to gain approval (in metastatic melanoma in December 2014 in Japan), but Merck &Co’s Keytruda has emerged as

Pfizer closes on EU approval of lung cancer drug Vizimpro

Pfizer closes on EU approval of lung cancer drug Vizimpro The drug is also under regulatory review for this indication in the US and Japan, and the new use could help AZ compete in the market with SGLT2 rivals Invokana (canagliflozin)

Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates

Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates Ashfield operates across a further three regions – US, Japan and Europe, but hopes the new alliance will provide further expertise in data-driven market and events management.

IQVIA sees market slowdown looming for pharma

IQVIA sees market slowdown looming for pharma the next few years in the 3% to 6% range, mainly due to sluggish growth in Europe, and static or shrinking sales in Japan. ... On the other hand, in Japan for example it says that growth in new products will be strong and resistant to price cuts, despite

Unlocking the potential of science and technology in the UK

Unlocking the potential of science and technology in the UK The context here is worth keeping in mind. According to World Bank figures, Korea (4.2%), Japan (3.3%), the United States (2.8%), Germany (2.8%), Switzerland (2.4%), France

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics